These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38666795)

  • 1. Nationwide Incidence and Trends in Central Retinal Arterial Occlusion Management: A 5000-Patient Analysis.
    Subah G; Xu P; Zeller S; Nolan B; Lui A; Fortunato M; Feldstein E; Kafina M; Schloss ER; Elefant D; Chong J; Gandhi C; Al-Mufti F
    Cardiol Rev; 2024 Jul-Aug 01; 32(4):291-296. PubMed ID: 38666795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.
    Schrag M; Youn T; Schindler J; Kirshner H; Greer D
    JAMA Neurol; 2015 Oct; 72(10):1148-54. PubMed ID: 26258861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Vascular Ischemic Events in Patients With Central Retinal Artery Occlusion in the United States: A Nationwide Study 2003-2014.
    Mir TA; Arham AZ; Fang W; Alqahtani F; Alkhouli M; Gallo J; Hinkle DM
    Am J Ophthalmol; 2019 Apr; 200():179-186. PubMed ID: 30689989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular Management of Central Retinal Arterial Occlusion.
    Agarwal N; Gala NB; Baumrind B; Hansberry DR; Thabet AM; Gandhi CD; Prestigiacomo CJ
    Vasc Endovascular Surg; 2016 Nov; 50(8):579-581. PubMed ID: 28081693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States.
    Otite FO; Saini V; Sur NB; Patel S; Sharma R; Akano EO; Anikpezie N; Albright K; Schmidt E; Hoffman H; Gould G; Khandelwal P; Latorre JG; Malik AM; Sacco RL; Chaturvedi S
    Stroke; 2021 Aug; 52(8):2562-2570. PubMed ID: 34078107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of central retinal artery occlusion: clinical presentation and management.
    Varma DD; Cugati S; Lee AW; Chen CS
    Eye (Lond); 2013 Jun; 27(6):688-97. PubMed ID: 23470793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.
    Mac Grory B; Schrag M; Biousse V; Furie KL; Gerhard-Herman M; Lavin PJ; Sobrin L; Tjoumakaris SI; Weyand CM; Yaghi S;
    Stroke; 2021 Jun; 52(6):e282-e294. PubMed ID: 33677974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-retinal Arterial Cannulation using a Microneedle for Central Retinal Artery Occlusion.
    Kadonosono K; Yamane S; Inoue M; Yamakawa T; Uchio E
    Sci Rep; 2018 Jan; 8(1):1360. PubMed ID: 29358594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan.
    Kang EY; Lin YH; Wang NK; Yeung L; Luo C; Wu WC; Sun CC; Kang JH; Hung MJ; Chen TH
    BMJ Open; 2019 Feb; 9(2):e025455. PubMed ID: 30819710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic lysis therapy in retinal vascular occlusions].
    Hattenbach LO
    Ophthalmologe; 1998 Aug; 95(8):568-75. PubMed ID: 9782735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of mechanical thrombectomy following intravenous administration of recombinant tissue-type plasminogen activator for basilar artery occlusion.
    Deguchi I; Osada T; Kimura H; Hayashi T; Takahashi S; Takao M
    Clin Neurol Neurosurg; 2020 Jul; 194():105796. PubMed ID: 32247170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Trends in the Incidence Rates of Central Retinal Artery Occlusion in Korea From 2002 to 2015.
    Kim J; Byun SJ; Woo SJ; Park KH; Park SJ
    JAMA Ophthalmol; 2021 Apr; 139(4):399-405. PubMed ID: 33570556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Intravenous Thrombolysis Safe and Effective in Central Retinal Artery Occlusion? A Critically Appraised Topic.
    Dumitrascu OM; Shen JF; Kurli M; Aguilar MI; Marks LA; Demaerschalk BM; Wingerchuk DM; O'Carroll CB
    Neurologist; 2017 Jul; 22(4):153-156. PubMed ID: 28644261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!
    Dumitrascu OM; Newman NJ; Biousse V
    J Neuroophthalmol; 2020 Sep; 40(3):333-345. PubMed ID: 32739995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous tPA (Tissue-Type Plasminogen Activator) Correlates With Favorable Venous Outflow Profiles in Acute Ischemic Stroke.
    Faizy TD; Mlynash M; Marks MP; Christensen S; Kabiri R; Kuraitis GM; Broocks G; Winkelmeier L; Geest V; Nawabi J; Lansberg MG; Albers GW; Fiehler J; Wintermark M; Heit JJ
    Stroke; 2022 Oct; 53(10):3145-3152. PubMed ID: 35735008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1.
    Feltgen N; Neubauer A; Jurklies B; Schmoor C; Schmidt D; Wanke J; Maier-Lenz H; Schumacher M;
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):950-6. PubMed ID: 16372192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in acute retinal ischemia treated with tenecteplase.
    Kalaga SVP; Krishnan P; Krupa A L; Riyaz A; Vemula R
    Digit J Ophthalmol; 2024; 30(2):33-37. PubMed ID: 38962669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Management of Central Retinal Artery Occlusion the Next Frontier in Cerebrovascular Diseases?
    Limaye K; Wall M; Uwaydat S; Ali S; Shaban A; Al Kasab S; Adams H
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2781-2791. PubMed ID: 30060907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis for Acute Central Retinal Artery Occlusion.
    Wang X; Liu Y; Suo Y; Qin D; Ren M; Lei R; Zhang Y; Wang Y
    J Craniofac Surg; 2021 Jan-Feb 01; 32(1):313-316. PubMed ID: 33156166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.